Skip to main content

Table 2 Growth inhibition induced by transformed compounds against human lung cancer cell line (NCI-H460)

From: In-vitro immunomodulatory and anti-cancerous activities of biotransformed products of Dianabol through Azadirachta indica and its molecular docking studies

Compound(s) GI50(μM) TGI (μM)
1 28.3 ± 2.72 NDa
2 22.5 ± 4.15 60 ± 9.2
3 ND ND
Doxorubicin (control) 0.08 ± 0.02 ---
  1. aND: Values could not be determined indicates <50% inhibition of cell growth at maximum dose (100 μM) tested.